XDx
XDx
Transforming Transplant Patient Care.
Other | United States of America | Health Improvement |
Overview
CareDx, Inc., based in Brisbane, California, is a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value diagnostic surveillance solutions for transplant patients. The company has commercialized AlloMap®, a gene expression test that aids clinicians in identifying heart transplant patients with stable graft function who have a low probability of moderate/severe acute cellular rejection. CareDx is also pursuing the development of additional products for transplant monitoring using a variety of technologies, including AlloSure, its next-generation sequencing–based test, to detect donor-derived cell-free DNA after transplantation.
Industry |
Legal Structure |
Operating Status |
Employees |
| Other | Operating |
Funding and Financing Rounds
Undisclosed
Team
Impact
Geographies:
Social Objectives:
Environmental Objectives:
Operational Impact:
Impact Reports & Metrics
Offices
Headquarters
3260 Bayshore Blvd.
Brisbane, California 94005
United States of America